Krzysztof Filipiak to Coronary Artery Disease
This is a "connection" page, showing publications Krzysztof Filipiak has written about Coronary Artery Disease.
Connection Strength
0.414
-
Platelet to red cell distribution width ratio for predicting clopidogrel efficacy in patients undergoing percutaneous coronary interventions: insights from the ONSIDE-TEST study. Pol Arch Intern Med. 2019 02 28; 129(2):117-122.
Score: 0.266
-
Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry. Catheter Cardiovasc Interv. 2018 01 01; 91(1):115-123.
Score: 0.060
-
Optimal aNtiplatelet pharmacotherapy guided by bedSIDE genetic or functional TESTing in elective PCI patients: A pilot study: ONSIDE TEST pilot. Cardiol J. 2017; 24(3):284-292.
Score: 0.058
-
A serial three- and nine-year optical coherence tomography evaluation of neoatherosclerosis progression after sirolimus- and paclitaxel- -eluting stent implantation. Kardiol Pol. 2018; 76(8):1251-1256.
Score: 0.016
-
Cardiovascular risk factors determined via the Internet in 2 periods of time: 2004-2009 and 2010-2015 in Poland. Int J Occup Med Environ Health. 2017 May 08; 30(3):499-510.
Score: 0.015